Health & Biotech
Health Kick Podcast: Aroa sets sights on sales growth in FY25
Health & Biotech
Health Kick Podcast: Creating hope for debilitating diseases
Health & Biotech
Health Kick Podcast: Prescient Therapeutics an emerging global leader in the next generation of personalised cancer therapies.
Health & Biotech
HealthKick Podcast: Aussie biotech Dimerix expects first data from its DMX200 Phase 3 trial by end of year
Health & Biotech
Health Kick Podcast: Prescient Therapeutics’ PTX-100 continues to show encouraging results following FDA Orphan Drug Designation
Health & Biotech
Health Kick Podcast: EZZ signs agreement with University of Auckland to conduct product research
Health & Biotech
Health Kick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trial
Health & Biotech
HealthKick Podcast: PTX partners with the US’s largest cancer centre on personalised treatment
Health & Biotech
HealthKick Podcast: NGS’s growth just accelerated with launch into 403 select Walmart stores
Health & Biotech
HealthKick Podcast: Bionomic charges forward with lead drug candidate treatment for PTSD and social anxiety
Health & Biotech
Health Kick Podcast: How Osteopore is innovating in the area of bone and tissue regeneration
Tech
HealthKick Podcast: Audeara’s revenue up nearly 140pc YoY… and 50pc from the previous quarter
Health & Biotech
HealthKick Podcast: Life sciences expert on local medical innovations, tech leaders and sector opportunities
Health & Biotech
HealthKick Podcast: ASX biotech Dimerix gains momentum from involvement in multiple COVID-19 studies
Health & Biotech
Health Kick Podcast: How TALi Digital is using gamification to spot attention deficit issues in children
Health & Biotech
Health Kick: Wellnex CEO George Karafotias discusses the company’s wellness pivot, major licensing deal and new product suite
Health & Biotech
Health Kick Podcast: HitIQ has a revolutionary solution for the concussion problem in contact sports
Health & Biotech
Health Kick: Prescient Therapeutics’ YTD share price soars +220% after progress in clinical studies and CAR-T platform
Tech
Health Kick: New ASX listee Audeara uses algorithms to create perfect audio and better hearing health
Health & Biotech
Health Kick: Injectable contrast dyes have serious health impacts, Osprey Medical has the solution
Health & Biotech
Health Kick: CEO Rob Wong on how Control Bionics is enabling communication via brain signals
Health & Biotech
HealthKick Podcast: Kazia tackles the curse of US politicians with its innovative drug candidate
Health & Biotech
HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine
Health & Biotech
Health Kick: Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture
Health & Biotech
HealthKick Podcast: NSB brings new solutions to medicine’s most stubborn eye problems
Health & Biotech
Healthkick Podcast: Neuren is cashed up, confident and charging into a phase 3 trial
Health & Biotech
Health Kick Podcast: Osteopore’s expansion plans and new markets after 2019’s stellar IPO
Health & Biotech
Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Health & Biotech
Health Kick Podcast: Investors smell success in Rhinomed’s flu and coronavirus nasal swab technology
Health & Biotech
Health Kick Podcast: This biopharma company may be the world’s only exosome-based player
Health & Biotech
Health Kick Podcast: Investors love Apiam’s diversified pet and livestock vet offering
Health & Biotech
Health Kick Podcast: PainChek’s AI-backed pain assessment tech a game-changer for treating infants and the elderly
Health & Biotech
Health Kick Podcast: Investors still high on Incannex cannabinoid pivot and COVID-19 treatment news
Health & Biotech
Health Kick Podcast: Starpharma goes from strength to strength following news of progress on COVID-19 nasal spray
Health & Biotech
Health Kick Podcast: Cannpal has first mover advantage in the $67bn “hidden gem” animal health market
Health & Biotech
Health Kick Podcast: Chemo’s diminishing role, the ‘personalised’ approach to cancer treatment and PTX’s CAR-T innovations
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Health Kick: Pancreatic cancer treater OncoSil continues impressive bounce-back
Health & Biotech
Health Kick: This drug developer is up 200pc following inclusion in a COVID-19 related trial
Health & Biotech
Health Kick: Cynata’s stem cell therapy could be a game changer for COVID-19 patients
Health & Biotech
Health Kick: This stock has a clear vision for the future of contact lenses
Health & Biotech
Health Kick Podcast: Accurately measuring cognition offers massive upside to clinicians and drug makers; CGS has the tech
Health & Biotech
Health Kick Podcast: Can listed Aussie drug makers survive COVID-19?
Load More
Featured Health Kick Podcast Stocks
Health Kick Podcast
In his weekly “The Health Kick Podcast” Tim will interview Australia’s leading Health and Biotech industry leaders, bringing his own unique insight and perspective into the world of health and drug discovery.
